USA Non-Invasive Cancer Diagnostics Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such as rising demand for minimally invasive therapeutics and diagnosis for the treatment of cancer. Moreover, increasing prevalence of cancer because of rising aging population and unhealthy lifestyle is also important factor that is fueling the growth of this market.

    The global non invasive cancer diagnostics and technologies market is segmented into type and technology. Based on type this market is further sub segmented into breast cancer, blood cancer, lung cancer and solid tumors. Moreover, rising awareness amongst people about symptoms, diagnosis and therapies about breast cancer has contributed towards the dominance of this segment.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Non-Invasive Cancer Diagnostics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Non-Invasive Cancer Diagnostics market. Detailed analysis of key players, along with key growth strategies adopted by Non-Invasive Cancer Diagnostics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Affymetrix Inc

    • Gen-Probe Inc

    • BIOVIEW Inc

    • Quest Diagnostics Inc

    • AVIVA Biosciences Corporation

    • Digene Corporation

    • Cancer, Genetics Inc

    • Laboratory Corporation of America Holdings (LabCorp)

    • Precision Therapeutics

    • A&G Pharmaceutical

    By Type:

    • CTCs

    • CTNAS

    • Exosomes

    By End-User:

    • Blood

    • Urine

    • Saliva

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Non-Invasive Cancer Diagnostics Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Non-Invasive Cancer Diagnostics Market Size and Growth Rate of CTCs from 2016 to 2027

      • 1.3.2 USA Non-Invasive Cancer Diagnostics Market Size and Growth Rate of CTNAS from 2016 to 2027

      • 1.3.3 USA Non-Invasive Cancer Diagnostics Market Size and Growth Rate of Exosomes from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Non-Invasive Cancer Diagnostics Market Size and Growth Rate of Blood from 2016 to 2027

      • 1.4.2 USA Non-Invasive Cancer Diagnostics Market Size and Growth Rate of Urine from 2016 to 2027

      • 1.4.3 USA Non-Invasive Cancer Diagnostics Market Size and Growth Rate of Saliva from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Non-Invasive Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Non-Invasive Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Non-Invasive Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Non-Invasive Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Non-Invasive Cancer Diagnostics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Non-Invasive Cancer Diagnostics by Major Types

      • 3.4.1 Market Size and Growth Rate of CTCs

      • 3.4.2 Market Size and Growth Rate of CTNAS

      • 3.4.3 Market Size and Growth Rate of Exosomes

    4 Segmentation of Non-Invasive Cancer Diagnostics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Non-Invasive Cancer Diagnostics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Non-Invasive Cancer Diagnostics in Blood

      • 4.4.2 Market Size and Growth Rate of Non-Invasive Cancer Diagnostics in Urine

      • 4.4.3 Market Size and Growth Rate of Non-Invasive Cancer Diagnostics in Saliva

    5 Market Analysis by Regions

    • 5.1 USA Non-Invasive Cancer Diagnostics Production Analysis by Regions

    • 5.2 USA Non-Invasive Cancer Diagnostics Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Non-Invasive Cancer Diagnostics Landscape Analysis

    • 6.1 West USA Non-Invasive Cancer Diagnostics Landscape Analysis by Major Types

    • 6.2 West USA Non-Invasive Cancer Diagnostics Landscape Analysis by Major End-Users

    7 South USA Non-Invasive Cancer Diagnostics Landscape Analysis

    • 7.1 South USA Non-Invasive Cancer Diagnostics Landscape Analysis by Major Types

    • 7.2 South USA Non-Invasive Cancer Diagnostics Landscape Analysis by Major End-Users

    8 Middle West USA Non-Invasive Cancer Diagnostics Landscape Analysis

    • 8.1 Middle West USA Non-Invasive Cancer Diagnostics Landscape Analysis by Major Types

    • 8.2 Middle West USA Non-Invasive Cancer Diagnostics Landscape Analysis by Major End-Users

    9 Northeast USA Non-Invasive Cancer Diagnostics Landscape Analysis

    • 9.1 Northeast USA Non-Invasive Cancer Diagnostics Landscape Analysis by Major Types

    • 9.2 Northeast USA Non-Invasive Cancer Diagnostics Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Affymetrix Inc

        • 10.1.1 Affymetrix Inc Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Gen-Probe Inc

        • 10.2.1 Gen-Probe Inc Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 BIOVIEW Inc

        • 10.3.1 BIOVIEW Inc Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Quest Diagnostics Inc

        • 10.4.1 Quest Diagnostics Inc Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 AVIVA Biosciences Corporation

        • 10.5.1 AVIVA Biosciences Corporation Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Digene Corporation

        • 10.6.1 Digene Corporation Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Cancer, Genetics Inc

        • 10.7.1 Cancer, Genetics Inc Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Laboratory Corporation of America Holdings (LabCorp)

        • 10.8.1 Laboratory Corporation of America Holdings (LabCorp) Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Precision Therapeutics

        • 10.9.1 Precision Therapeutics Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 A&G Pharmaceutical

        • 10.10.1 A&G Pharmaceutical Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Non-Invasive Cancer Diagnostics Market Size and Growth Rate of CTCs from 2016 to 2027

    • Figure USA Non-Invasive Cancer Diagnostics Market Size and Growth Rate of CTNAS from 2016 to 2027

    • Figure USA Non-Invasive Cancer Diagnostics Market Size and Growth Rate of Exosomes from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Non-Invasive Cancer Diagnostics Market Size and Growth Rate of Blood from 2016 to 2027

    • Figure USA Non-Invasive Cancer Diagnostics Market Size and Growth Rate of Urine from 2016 to 2027

    • Figure USA Non-Invasive Cancer Diagnostics Market Size and Growth Rate of Saliva from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Non-Invasive Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Non-Invasive Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Non-Invasive Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Non-Invasive Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Non-Invasive Cancer Diagnostics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Non-Invasive Cancer Diagnostics

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Non-Invasive Cancer Diagnostics by Different Types from 2016 to 2027

    • Table Consumption Share of Non-Invasive Cancer Diagnostics by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of CTCs

    • Figure Market Size and Growth Rate of CTNAS

    • Figure Market Size and Growth Rate of Exosomes

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Non-Invasive Cancer Diagnostics by Different End-Users from 2016 to 2027

    • Table Consumption Share of Non-Invasive Cancer Diagnostics by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Blood

    • Figure Market Size and Growth Rate of Urine

    • Figure Market Size and Growth Rate of Saliva

    • Table USA Non-Invasive Cancer Diagnostics Production by Regions

    • Table USA Non-Invasive Cancer Diagnostics Production Share by Regions

    • Figure USA Non-Invasive Cancer Diagnostics Production Share by Regions in 2016

    • Figure USA Non-Invasive Cancer Diagnostics Production Share by Regions in 2021

    • Figure USA Non-Invasive Cancer Diagnostics Production Share by Regions in 2027

    • Table USA Non-Invasive Cancer Diagnostics Consumption by Regions

    • Table USA Non-Invasive Cancer Diagnostics Consumption Share by Regions

    • Figure USA Non-Invasive Cancer Diagnostics Consumption Share by Regions in 2016

    • Figure USA Non-Invasive Cancer Diagnostics Consumption Share by Regions in 2021

    • Figure USA Non-Invasive Cancer Diagnostics Consumption Share by Regions in 2027

    • Table West USA Non-Invasive Cancer Diagnostics Consumption by Types from 2016 to 2027

    • Table West USA Non-Invasive Cancer Diagnostics Consumption Share by Types from 2016 to 2027

    • Figure West USA Non-Invasive Cancer Diagnostics Consumption Share by Types in 2016

    • Figure West USA Non-Invasive Cancer Diagnostics Consumption Share by Types in 2021

    • Figure West USA Non-Invasive Cancer Diagnostics Consumption Share by Types in 2027

    • Table West USA Non-Invasive Cancer Diagnostics Consumption by End-Users from 2016 to 2027

    • Table West USA Non-Invasive Cancer Diagnostics Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Non-Invasive Cancer Diagnostics Consumption Share by End-Users in 2016

    • Figure West USA Non-Invasive Cancer Diagnostics Consumption Share by End-Users in 2021

    • Figure West USA Non-Invasive Cancer Diagnostics Consumption Share by End-Users in 2027

    • Table South USA Non-Invasive Cancer Diagnostics Consumption by Types from 2016 to 2027

    • Table South USA Non-Invasive Cancer Diagnostics Consumption Share by Types from 2016 to 2027

    • Figure South USA Non-Invasive Cancer Diagnostics Consumption Share by Types in 2016

    • Figure South USA Non-Invasive Cancer Diagnostics Consumption Share by Types in 2021

    • Figure South USA Non-Invasive Cancer Diagnostics Consumption Share by Types in 2027

    • Table South USA Non-Invasive Cancer Diagnostics Consumption by End-Users from 2016 to 2027

    • Table South USA Non-Invasive Cancer Diagnostics Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Non-Invasive Cancer Diagnostics Consumption Share by End-Users in 2016

    • Figure South USA Non-Invasive Cancer Diagnostics Consumption Share by End-Users in 2021

    • Figure South USA Non-Invasive Cancer Diagnostics Consumption Share by End-Users in 2027

    • Table Middle West USA Non-Invasive Cancer Diagnostics Consumption by Types from 2016 to 2027

    • Table Middle West USA Non-Invasive Cancer Diagnostics Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Non-Invasive Cancer Diagnostics Consumption Share by Types in 2016

    • Figure Middle West USA Non-Invasive Cancer Diagnostics Consumption Share by Types in 2021

    • Figure Middle West USA Non-Invasive Cancer Diagnostics Consumption Share by Types in 2027

    • Table Middle West USA Non-Invasive Cancer Diagnostics Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Non-Invasive Cancer Diagnostics Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Non-Invasive Cancer Diagnostics Consumption Share by End-Users in 2016

    • Figure Middle West USA Non-Invasive Cancer Diagnostics Consumption Share by End-Users in 2021

    • Figure Middle West USA Non-Invasive Cancer Diagnostics Consumption Share by End-Users in 2027

    • Table Northeast USA Non-Invasive Cancer Diagnostics Consumption by Types from 2016 to 2027

    • Table Northeast USA Non-Invasive Cancer Diagnostics Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Non-Invasive Cancer Diagnostics Consumption Share by Types in 2016

    • Figure Northeast USA Non-Invasive Cancer Diagnostics Consumption Share by Types in 2021

    • Figure Northeast USA Non-Invasive Cancer Diagnostics Consumption Share by Types in 2027

    • Table Northeast USA Non-Invasive Cancer Diagnostics Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Non-Invasive Cancer Diagnostics Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Non-Invasive Cancer Diagnostics Consumption Share by End-Users in 2016

    • Figure Northeast USA Non-Invasive Cancer Diagnostics Consumption Share by End-Users in 2021

    • Figure Northeast USA Non-Invasive Cancer Diagnostics Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Affymetrix Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Affymetrix Inc

    • Figure Sales and Growth Rate Analysis of Affymetrix Inc

    • Figure Revenue and Market Share Analysis of Affymetrix Inc

    • Table Product and Service Introduction of Affymetrix Inc

    • Table Company Profile and Development Status of Gen-Probe Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gen-Probe Inc

    • Figure Sales and Growth Rate Analysis of Gen-Probe Inc

    • Figure Revenue and Market Share Analysis of Gen-Probe Inc

    • Table Product and Service Introduction of Gen-Probe Inc

    • Table Company Profile and Development Status of BIOVIEW Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BIOVIEW Inc

    • Figure Sales and Growth Rate Analysis of BIOVIEW Inc

    • Figure Revenue and Market Share Analysis of BIOVIEW Inc

    • Table Product and Service Introduction of BIOVIEW Inc

    • Table Company Profile and Development Status of Quest Diagnostics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quest Diagnostics Inc

    • Figure Sales and Growth Rate Analysis of Quest Diagnostics Inc

    • Figure Revenue and Market Share Analysis of Quest Diagnostics Inc

    • Table Product and Service Introduction of Quest Diagnostics Inc

    • Table Company Profile and Development Status of AVIVA Biosciences Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AVIVA Biosciences Corporation

    • Figure Sales and Growth Rate Analysis of AVIVA Biosciences Corporation

    • Figure Revenue and Market Share Analysis of AVIVA Biosciences Corporation

    • Table Product and Service Introduction of AVIVA Biosciences Corporation

    • Table Company Profile and Development Status of Digene Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Digene Corporation

    • Figure Sales and Growth Rate Analysis of Digene Corporation

    • Figure Revenue and Market Share Analysis of Digene Corporation

    • Table Product and Service Introduction of Digene Corporation

    • Table Company Profile and Development Status of Cancer, Genetics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cancer, Genetics Inc

    • Figure Sales and Growth Rate Analysis of Cancer, Genetics Inc

    • Figure Revenue and Market Share Analysis of Cancer, Genetics Inc

    • Table Product and Service Introduction of Cancer, Genetics Inc

    • Table Company Profile and Development Status of Laboratory Corporation of America Holdings (LabCorp)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Laboratory Corporation of America Holdings (LabCorp)

    • Figure Sales and Growth Rate Analysis of Laboratory Corporation of America Holdings (LabCorp)

    • Figure Revenue and Market Share Analysis of Laboratory Corporation of America Holdings (LabCorp)

    • Table Product and Service Introduction of Laboratory Corporation of America Holdings (LabCorp)

    • Table Company Profile and Development Status of Precision Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Precision Therapeutics

    • Figure Sales and Growth Rate Analysis of Precision Therapeutics

    • Figure Revenue and Market Share Analysis of Precision Therapeutics

    • Table Product and Service Introduction of Precision Therapeutics

    • Table Company Profile and Development Status of A&G Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of A&G Pharmaceutical

    • Figure Sales and Growth Rate Analysis of A&G Pharmaceutical

    • Figure Revenue and Market Share Analysis of A&G Pharmaceutical

    • Table Product and Service Introduction of A&G Pharmaceutical


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.